TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Omthera Pharmaceuticals Inc (NASDAQ:OMTH) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties In Takeover

  • If you purchased shares of Omthera Pharmaceuticals Inc (NASDAQ:OMTH) prior to May 28, 2013, and currently hold any of those NASDAQ:OMTH shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

May 29, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Omthera Pharmaceuticals Inc (NASDAQ:OMTH) shares was announced concerning whether the offer by AstraZeneca to acquire Omthera Pharmaceuticals Inc for $12.70 per NASDAQ:OMTH share and the takeover process are unfair to investors in NASDAQ:OMTH shares. The investigation by a law firm concerns whether ce...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: